DCF — OZARK HEALTH INC
Enterprise Value: $-27.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-27.4M
Enterprise Value
$-9.2M
PV of Cash Flows
$-18.2M
PV of Terminal Value
$-29.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $33.3M | $-1.4M | -4.0% | $-2.8M | $-2.6M |
| Year 2 | $34.3M | $-1.1M | -3.0% | $-2.6M | $-2.1M |
| Year 3 | $35.3M | $-0.8M | -2.0% | $-2.3M | $-1.7M |
| Year 4 | $36.4M | $-0.6M | -2.0% | $-2.2M | $-1.5M |
| Year 5 | $37.5M | $-0.6M | -1.0% | $-2.1M | $-1.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-27.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$32.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04748073470607437
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5